The Role of Randall's Plaques in Urolithiasis. Foreword

Overview

Journal Urolithiasis

Publisher Springer

Specialty Urology

Date 2014 Sep 15

PMID 25218780

Citations 2

Authors

Saeed R Khan

Affiliations

Soon will be listed here.

Citing Articles

α-Klotho released from HK-2 cells inhibits osteogenic differentiation of renal interstitial fibroblasts by inactivating the Wnt-β-catenin pathway.

Zhu Z, Ruan S, Jiang Y, Huang F, Xia W, Chen J Cell Mol Life Sci. 2021; 78(23):7831-7849.

PMID: 34724098 PMC: 11071709. DOI: 10.1007/s00018-021-03972-x.

Osteogenic Differentiation of Renal Interstitial Fibroblasts Promoted by lncRNA May Partially Contribute to Randall's Plaque Formation.

Zhu Z, Huang F, Xia W, Zeng H, Gao M, Li Y Front Cell Dev Biol. 2021; 8:596363.

PMID: 33505960 PMC: 7829506. DOI: 10.3389/fcell.2020.596363.

References

Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U . Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346(2):77-84. DOI: 10.1056/NEJMoa010369. View

Obligado S, Goldfarb D . The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008; 21(3):257-64. DOI: 10.1038/ajh.2007.62. View

Randall A . THE ORIGIN AND GROWTH OF RENAL CALCULI. Ann Surg. 1937; 105(6):1009-27. PMC: 1390483. DOI: 10.1097/00000658-193706000-00014. View

Coe F, Keck J, Norton E . The natural history of calcium urolithiasis. JAMA. 1977; 238(14):1519-23. View

Raynal G, Petit J, Saint F . Which efficiency index for urinary stones treatment?. Urol Res. 2009; 37(4):237-9. DOI: 10.1007/s00240-009-0200-x. View

Daudon M, Jungers P . Diabetes and nephrolithiasis. Curr Diab Rep. 2008; 7(6):443-8. DOI: 10.1007/s11892-007-0075-6. View

Randall A . Recent Advances in Knowledge Relating to the Formation, Recognition and Treatment of Kidney Calculi. Bull N Y Acad Med. 2009; 20(9):473-84. PMC: 1870034. View

Lipkin M, Preminger G . Demystifying the medical management of nephrolithiasis. Rev Urol. 2011; 13(1):34-8. PMC: 3151585. View

Khan S . Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?. Urol Res. 2012; 40(2):95-112. PMC: 5683185. DOI: 10.1007/s00240-011-0448-9. View

10.

Fink H, Wilt T, Eidman K, Garimella P, MacDonald R, Rutks I . Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013; 158(7):535-43. DOI: 10.7326/0003-4819-158-7-201304020-00005. View

11.

Jungers P, Joly D, Barbey F, Choukroun G, Daudon M . ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis. 2004; 44(5):799-805. View